aThis work reports on the synthesis and characterization of Pd x Cu 1−x (x = 0.7, 0.5 and 0.3) nanoalloys obtained via an eco-friendly chemical reduction method based on ascorbic acid and trisodium citrate.The average size of the quasi-spherical nanoparticles (NPs) obtained by this method was about 4 nm, as observed by TEM. The colloids containing different NPs were then supported on carbon in order to produce powder samples (Pd x Cu 1−x /C) whose electronic and structural properties were probed by different techniques. XRD analysis indicated the formation of crystalline PdCu alloys with a nanoscaled crystallite size. Core-level XPS results provided a fingerprint of a charge transfer process between Pd and Cu and its dependency on the nanoalloy composition. Additionally, it was verified that alloying was able to change the NP's reactivity towards oxidation and reduction. Indeed, the higher the amount of Pd in the nanoalloy, less oxidized are both the Pd and the Cu atoms in the as-prepared samples. Also, in situ XANES experiments during thermal treatment under a reducing atmosphere showed that the temperature required for a complete reduction of the nanoalloys depends on their composition. These results envisage the control at the atomic level of novel catalytic properties of such nanoalloys.
Melting and freezing of metallic nanoparticles embedded in glass matrices usually occur at temperatures lower than for the same metal in the bulk state. In situ small-angle X-ray scattering (SAXS) measurements using a synchrotron beamline and a specially designed high-temperature chamber allowed the determination of the temperature dependence of the SAXS intensity produced by a dilute and nearly monodisperse set of spherical Pb nanoparticles, with an average radius hRi = 16.1 nm, embedded in a homogeneous lead-borate oxide glass. The temperature dependences of the nanoparticle volume V(T) and nanoparticle radius of gyration R g (T) derived from SAXS results exhibit clear discontinuities during the cooling and during the heating processes, thus allowing for precise determinations of the melting and freezing temperatures of the studied Pb nanoparticles. Additional features observed in both V(T) and R g (T) curves showed that during the heating cycle the frozen Pb nanoparticles suffer a transition to a more compact phase at 433 K before melting at 580 K. The results of this work demonstrate that the melting and freezing temperatures of nanoparticles in a very diluted state -for which the X-ray diffraction technique is not sensitive enough -can be precisely determined by applying only the SAXS method.
In situ X-ray absorption spectroscopy and mass spectrometry measurements were employed to simultaneously probe the atom specific short range order and reactivity of Pd and PtPd nanoparticles towards NO decomposition at 300 °C. The nanoparticles were synthesized by a well controlled, eco-friendly wet chemical reduction of metal salts and later supported on activated carbon. Particularly for the bimetallic PtPd samples, distinct atomic arrangements were achieved using a seeding growth method, which allowed producing a random nanoalloy, or nanoparticles with Pt- or Pd-rich core. X-ray photoelectron spectroscopy, transmission electron microscopy, and X-ray diffraction provided additional insights on their electronic, morphological and long range order structural properties. The results revealed that the higher the thermal induced atomic migration observed within the nanoparticles during thermal treatments, the least were their reactivity for NO abatement.
The present study has tracked the changes in the electronic and structural properties of Pd–Cu nanoalloys that were influenced by the composition and chosen support.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.